curious_reader
TL1 Member · Ostrava, CZ
Not using anything. Reading because the analytical discussions are genuinely interesting.
Joined 11 February 2025 · last posted 18d
32 posts, newest first. Showing up to 150.
-
How much context is too much context in a first post? Replied, post #66 · Start Here › How to Ask · 9 Jul 2026 · 0 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
-
Request: tag synonyms surfaced in search Replied, post #14 · Meta › Feature requests · 8 Jul 2026 · 0 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible.
-
Official shortage notices and what they authorise Replied, post #101 · Access › Shortages · 12 Jun 2026 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Injection volume, overload, and peak distortion Replied, post #42 · Analytics › HPLC & UHPLC · 9 Jun 2026 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pancreatitis history and the risk calculus Replied, post #16 · Safety › Contraindications · 5 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: A pooled estimate that changed when one trial was added Replied, post #18 · Evidence › Meta-analyses · 31 May 2026 · 0 likes Picking up post #15: that is the part I would want checked first. Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #21 · Pharmacology › Pharmacokinetics · 31 May 2026 · 27 likes post #20 is right about the mechanism and I think understates the practical bit. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
-
Batch numbers that do not match the vial label — what changed since Replied, post #23 · Sourcing › Red flags · 27 May 2026 · 2 likes This follows post #20 rather than contradicting it. Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower…
-
Private prescribing in the UK: what is actually involved Replied, post #17 · Regional › UK & Ireland · 17 May 2026 · 9 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #24 · Practice › Administration · 7 May 2026 · 4 likes Worth separating two things that post #20 runs together. A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #48 · Practice › Administration · 5 Apr 2026 · 19 likes post #47 answers the question as asked. The question underneath it is different. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue…
-
Preprint servers and what screening they do Replied, post #100 · Evidence › Preprints · 23 Mar 2026 · 0 likes Preprints for speed: some important preliminary findings are posted as preprints to disseminate quickly. That speed is useful but comes at the cost of not yet having…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #15 · Practice › Administration · 15 Mar 2026 · 23 likes A site rotation scheme that actually works: abdomen, outer thigh, back of arm, outer hip. Rotate through them in order, move a minimum 2 cm between consecutive sites,…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 26 Feb 2026 · 1 like Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #51 · Practice › Interactions · 13 Feb 2026 · 4 likes Coming back to post #49, because the follow-up matters more than the original answer. Alcohol: no absolute contraindication but it raises gastrointestinal irritation…
-
[2026 update] Composite endpoints and the component doing the work Started this topic · Evidence › Trials · 9 Feb 2026 · 3 likes On the subject in the title: Composite endpoints and the component doing the work Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022)…
-
Angle of injection and whether 90 degrees is always right Replied, post #88 · Practice › Administration · 24 Jan 2026 · 21 likes Worth separating two things that post #84 runs together. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort),…
-
A history of disordered eating: proceeding carefully Replied, post #65 · Wellbeing › Mental health · 18 Jan 2026 · 17 likes On post #61 — agreed on the reasoning, with one qualification. Social and relationship impacts: weight change affects how others perceive and interact with a person.…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #9 · Regional › UK & Ireland · 13 Jan 2026 · 5 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #86 · Practice › Side effects · 29 Dec 2025 · 2 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Coming back to: Feature request: should a dose-equivalence tool exist at all? Replied, post #37 · Data & Tools › Calculators · 12 Dec 2025 · 20 likes post #36 answers the question as asked. The question underneath it is different. Reconstitution calculator: enter vial mass, final volume target, and the calculator…
-
Oral semaglutide bioavailability and its variability between people Replied, post #19 · Compounds › Oral incretins · 5 Dec 2025 · 0 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Meeting a protein target on a suppressed appetite Replied, post #39 · Nutrition & Training › Protein & intake · 1 Dec 2025 · 0 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
Temperature loggers worth the money Replied, post #18 · Devices › Cold chain · 13 Aug 2025 · 0 likes On post #14 — agreed on the reasoning, with one qualification. Travel with medication: carrying a vial across borders requires planning if temperatures will exceed the…
-
Reading a supplier's product description as a marketing document Replied, post #51 · Compounds › Other compounds · 30 Jul 2025 · 1 like This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #65 · Compounds › Other compounds · 12 Jun 2025 · 24 likes On post #61 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound is…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #87 · Compounds › Tirzepatide · 18 May 2025 · 2 likes Coming back to post #85, because the follow-up matters more than the original answer. Storage and stability: published data on licensed tirzepatide formulations exists…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #59 · Compounds › Secretagogues & GH axis · 10 May 2025 · 1 like Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Charge states for a 4 kDa peptide, worked through Replied, post #137 · Analytics › Mass spectrometry · 17 Mar 2025 · 2 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #25 · Wellbeing › Mental health · 5 Mar 2025 · 0 likes Substance use: if someone has a history of substance use, appetite suppression and weight loss can shift thinking about body and substance use. This is a risk factor…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #50 · Compounds › Cagrilintide & amylin analogues · 14 Jan 2025 · 3 likes Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms. Whether the slowing at a higher magnitude produces disproportionate…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #43 · Evidence › Journal club · 26 Nov 2024 · 22 likes Worth separating two things that post #39 runs together. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in…